University of Cincinnati Selected to Test New Vaccine
June 20, 2019
June 20, 2019
CINCINNATI, Ohio, June 20 -- The University of Cincinnati issued the following news:
* * *
- UC Medical Center will serve as one of several global locations to test HB-101 vaccine in transplant patients
* * *
The University of Cincinnati and its affiliated health system, UC Health, will serve as one of several international locations to test an investigational vaccine to prevent cytomegalovirus (CMV) in people who have had a kidney transplant. . . .
* * *
- UC Medical Center will serve as one of several global locations to test HB-101 vaccine in transplant patients
* * *
The University of Cincinnati and its affiliated health system, UC Health, will serve as one of several international locations to test an investigational vaccine to prevent cytomegalovirus (CMV) in people who have had a kidney transplant. . . .